EMEND

Generic: FOSAPREPITANT DIMEGLUMINE

Merck Sharp & Dohme LLCManufacturer
INTRAVENOUSRoute
FOSAPREPITANT DIMEGLUMINEActive Substance
2008-01-25Original Approval

EMEND is FDA application NDA022023, sponsored by MERCK AND CO INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2025-12-12
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme L

Presence of particulate matter: potential presence of metal particulates in the product.

Top Reported Reactions

1
NAUSEA
2,272 reports
2
FATIGUE
1,977 reports
3
PYREXIA
1,697 reports
4
DYSPNOEA
1,639 reports
5
DIARRHOEA
1,626 reports
6
VOMITING
1,564 reports
7
OFF LABEL USE
1,455 reports
8
ALOPECIA
1,384 reports
9
RASH
1,303 reports
10
HYPERSENSITIVITY
1,218 reports